First Global Estimates of 2009 H1N1 Pandemic Mortality Released by CDC-Led Collaboration
These global estimates are more than 15 times higher than the number of laboratory-confirmed deaths reported to the World Health Organization (WHO). WHO has acknowledged for some time that official, lab-confirmed reports are an underestimate of actual number of influenza deaths. Diagnostic specimens are not always collected from people who die with influenza; for others, influenza virus may not be detectable by the time of death. Because of these challenges, modeling is used to estimate the actual burden of disease.
Influenza Disease Mortality Burden
While studies looking at the burden of the 2009 H1N1 pandemic by country have been published previously, this is the first study to assess the global mortality impact of the pandemic. The authors of the study had to overcome numerous challenges to arrive at these estimates, including lack of data specific to influenza in many countries, variability in terms of the level and timing of influenza virus circulation and differences across countries based on socio-economic factors listed above. They did this by using influenza surveillance data from high-, middle- and low-income countries, case fatality ratios reported from high income countries and the World Health Organization Burden of Disease data on lower respiratory tract infection mortality.
The estimated number of deaths from this model was similar to previous mortality estimates during the first 12 months of 2009 H1N1 virus circulation in some countries, including the United States.
According to the study, the largest death burden may have occurred in countries in the African and Southeast Asian regions, where it was estimated that more than half of all 2009 H1N1-related deaths occurred. These regions are home to 38 percent of the world’s population. People living in these countries may be at higher risk for death from influenza complications due to differences in access to and quality of health care, nutritional status, the prevalence of underlying conditions, the age structure of the population and limited availability of influenza vaccines and antiviral medications.
“The lack of mortality estimates in low- and middle-income countries represents an important knowledge gap in understanding the impact of the 2009 H1N1 pandemic on the world’s population,” says study author Dr. Fatimah Dawood of CDC.
2009 H1N1 Pandemic Hits the Young Especially Hard
“Ongoing efforts to strengthen influenza surveillance worldwide, particularly for influenza-associated mortality, are needed both to guide seasonal influenza prevention strategies and to build influenza surveillance systems to provide better, more timely, and globally representative data for influenza-associated mortality during future pandemics,” says Dawood.
This study estimated that 80% of 2009 H1N1 deaths were in people younger than 65 years of age which differs from typical seasonal influenza epidemics during which 80-90% of deaths are estimated to occur in people 65 years of age and older. To illustrate the impact of the shift in the age distribution of influenza deaths to younger age groups during the pandemic, researchers calculated the number of years of life lost due to 2009 H1N1-associated deaths. They estimated that 3 times as many years of life were lost during the first year of 2009 H1N1 virus circulation than would have occurred for the same number of deaths during a typical influenza season.
“Previous studies have documented that people younger than 65 years were more affected by the 2009 H1N1 pandemic than during typical influenza seasons. Our estimates support this observation and our analysis of years of life lost during the first year of the 2009 H1N1 pandemic underscores the impact that this pandemic had in comparison to typical seasonal influenza epidemics,” says Dawood.
Though the most recent influenza pandemic was hard on the young, the impact on the global population overall during the first year was less severe than that of previous pandemics. Estimates of pandemic influenza mortality ranged from 0.03% of the world’s population during the 1968 pandemic to 1–3% of the world’s population during the 1918 pandemic. It was estimated that 0.001–0.007% of the world’s population died of respiratory complications associated with 2009 H1N1 virus infection during the first 12 months the virus circulated (or 0.001–0.011% when cardiovascular deaths were included).
Because respiratory or cardiovascular influenza-related complications can lead to death, researchers estimated both respiratory and cardiovascular deaths to reach a total global estimate of mortality. An estimated 105,700-395,600 respiratory deaths occurred, while an additional 46,000-179,900 deaths were attributed to cardiovascular complications. (Influenza-associated cardiovascular deaths were only estimated in persons 18 years of age and older since cardiovascular complications are relatively rare in children younger than 18 years.)
This study’s approach to measuring the impact of 2009 H1N1 shows progress toward more accurate estimates of global mortality and advances understanding of the burden of influenza around the world, while the volume of estimated 2009 H1N1 deaths underscores the need for CDC’s continued commitment to influenza prevention and control activities around the world.
“Ongoing efforts to strengthen influenza surveillance worldwide, particularly for influenza-associated mortality, are needed both to guide seasonal influenza prevention strategies and to build influenza surveillance systems to provide better, more timely, and globally representative data for influenza-associated mortality during future pandemics,” says Dawood.
Source: Dawood, F. S., Iuliano, A.D., Reed, C., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012 Jun 26. [Online First]
